Decreased BDNF concentration has been reported in serum and CSF of AD patients, with a significantly positive relationship between the degree of decline and the severity of cognitive dysfunction (Li et al., 2009; Ng et al., 2019). This evidence concerns the gene BDNF and Alzheimer disease.